Intended for healthcare professionals
Over 100 000 people with type 1 diabetes in England should be offered new technology to help them control their condition with little human input, the National Institute for Health and Care Excellence (NICE) has advised.
In draft guidance1 published on 10 January, an independent NICE committee recommended the use of hybrid “closed loop” systems for managing blood glucose levels in type 1 diabetes.
The technology, described as a step towards an artificial pancreas, automatically balances blood glucose levels through a continuous glucose monitor sensor that transmits data to a body worn insulin pump. The pump delivers insulin directly to the bloodstream when required. …
BMA Member Log In
If you have a subscription to The BMJ, log in:
Subscribe and get access to all BMJ articles, and much more.
Subscribe
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.
Buy this article
Respond to this article
Register for alerts
If you are unable to import citations, please contact technical support for your product directly (links go to external sites):
Thank you for your interest in spreading the word about The BMJ.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. 
Read related article
See previous polls